Abstract Daiichi Sankyo recently announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved the HER2-targeted antibody conjugate … Continue reading HER2, the first ADC drug for HER2-positive gastric cancer, approved in Japan